TCRTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Alaunos Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$3.13+0.50 (+19.01%)
Close on Oct 19, 2026
- Market cap
- $7.61M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Aug 14, 2024(first seen in filings) | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| Jul 18, 2024 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| Apr 1, 2024(first seen in filings) | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |
| Feb 1, 2024 | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |